TrinityTrinity
Longevity & Mitochondrial Peptides

NAD+ in 2026: Head-to-Head NMN vs NR Trials, Dosing & Aging Research

Michael Court
September 12, 2026
6 min read

NAD+ demand is booming in wellness clinics, but controlled trial data is only catching up now. Here is what 2026's head-to-head NMN vs NR studies, decline research, and dosing literature actually show.